Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      Apnimed Announces Pricing of Upsized Initial Public Offering
      Biotech

      Apnimed Announces Pricing of Upsized Initial Public Offering

      July 31, 2026
      Agios Reports Second Quarter 2026 Financial Results and Provides Business Update
      Biotech

      Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

      July 30, 2026
      Amneal Reports Second Quarter 2026 Financial Results
      Biotech

      Amneal Reports Second Quarter 2026 Financial Results

      July 30, 2026
      Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use
      Biotech

      Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use

      July 30, 2026
      Fortrea Reports Second Quarter 2026 Results
      Biotech

      Fortrea Reports Second Quarter 2026 Results

      July 29, 2026
      Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
      Biotech

      Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

      July 29, 2026
      AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
      Biotech

      AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo

      July 29, 2026
      AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
      Biotech

      AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

      July 29, 2026
      Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
      Biotech

      Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

      July 17, 2026
      Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
      Biotech

      Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

      July 16, 2026
      « 1 … 14 15 16 17 18 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026